<DOC>
	<DOC>NCT01120873</DOC>
	<brief_summary>To evaluate the effect of Metamin 3D on improvement of glucose and lipid on Taiwanese subjects with metabolic syndrome.</brief_summary>
	<brief_title>The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome</brief_title>
	<detailed_description>The Metamin 3D consists of mixed extractives of nature plants, including soy bean protein, bitter melon, red yeast rice, green algae and trisodium glycyrrhizinate. the improvement of lipid and glucose was reported respectively previously. We design a prospective, double-blinded and placebo-controlled study to evaluate the improvement on metabolic syndrome.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Age between 30 and 75 years Fasting plasma glucose &gt;= 100 mg/dl Triglyceride &gt;= 150 mg/dl one of the criteria following 1. HDL &lt;40 mg/dl in man or &lt;50 mg/dl in woman 2. Blood pressure &gt;= 135/85 mmHg or antihypertension drug treatment 3. Waist &gt;90cm in man or 80cm in woman Signed the inform consent Fasting plasma glucose &gt; 180mg/dl Treated by more than two types oral hypoglycemic agents in past 3 months Treated continuously by antilipid agents for 3 months in past 6 months Treated by thiazolidinedione or digitalis at present Serum creatine &gt; 2.5mg/dl Liver function (GOT or GPT) more than 3fold upper limit Severe systemic disease by investigator's judgement Pregnant or nursing women Enrolled in other clinical study in recent 1 month</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Hyperglycemia</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Obesity</keyword>
</DOC>